Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page
- Check2 days agoChange DetectedThe page now shows revision v3.6.2 in place of v3.6.0, indicating a routine site update. The change does not modify study details or interactions on the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows that recruitment has ended, and additional navigation/help sections were added or updated to improve access to study information.SummaryDifference0.6%

- Check23 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating a frontend update. No study data or content has changed.SummaryDifference0.0%

- Check45 days agoChange DetectedThe footer now shows Revision: v3.5.4, updating the site version reference. This reflects a new build of the page template and does not alter study data or visible content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.